Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Nordic Bifurcation Study III (BIF III)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Johnson & Johnson
Information provided by (Responsible Party):
Niels Ramsing Holm, Aarhus University Hospital Skejby
ClinicalTrials.gov Identifier:
NCT00914199
First received: June 3, 2009
Last updated: September 22, 2016
Last verified: September 2016